Mon, Jul 28, 2014, 4:15 AM EDT - U.S. Markets open in 5 hrs 15 mins

Recent

% | $
Click the to save as a favorite.

Cytosorbents Corporation Message Board

  • cruizon cruizon Sep 17, 2013 9:52 AM Flag

    Endless supply of .10's

    our ceiling. How much longer, D. Chan?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Not a ceiling but lifeline. Don't you find the PPS a bit suspicious?

      Who is purchasing these at .10 shares to maintain the LPC agreement? Is the company knowledgeable of this activity? Is this activity at the request of the company?

      2.2 million shares dumped at .10 on good news? Chan has stated he cares nothing about the PPS and it is obvious. Now with LPC deal at risk of drying up, it seems like they care enough to prop up the price.

      Keep buying while it's cheap! This will be a winner in-spite of mismanagement.

      Sentiment: Strong Buy

      • 2 Replies to xmes
      • And why do these people manipulate the price like this? Because they can.

      • You make a good point. There has been a continual stream of good news regarding the filter and its application for different indications, we're starting to hear of successful case studies, the hiring of well credentialed people . Yet the pps languishes at $0.10 pps. I see the real challenge for CTSO is that of financing. I think CTSO underestimated how much would be need - Dr. Chan said as winter that the doing study is going to take loner than what was originally expected. So the time horizon keeps getting pushed out further into the future.

        Only recently has the company spoke of debt financing. Obviously sales will offset debt and equity financing but once there is a influx of cash from a partnership that will end the arrangement with LPC.

 
CTSO
0.250.00(+1.01%)Jul 25 3:41 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Puma Biotechnology, Inc.
NYSEFri, Jul 25, 2014 4:01 PM EDT
Sohu.com Inc.
NasdaqGSFri, Jul 25, 2014 3:59 PM EDT